SCHEMBL5478260

SCHEMBL5478260

Nc1ncnc2scc(C(=O)Nc3ccc(NC(=O)Nc4ccccc4)cc3)c12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLK4 O00444 10/20 1.00
MAP4K4 O95819 10/20 1.00
MARK3 P27448 10/20 1.00
AXL P30530 10/20 1.00
MAP4K2 Q12851 10/20 1.00
STK3 Q13188 10/20 1.00
SLK Q9H2G2 10/20 1.00
MKNK2 Q9HBH9 10/20 1.00
LIMK1 P53667 9/20 1.00
MARK2 Q7KZI7 9/20 1.00
CLK4 Q9HAZ1 9/20 1.00
LCK P06239 9/20 1.00
BLK P51451 9/20 1.00
MINK1 Q8N4C8 8/20 1.00
BRSK1 Q8TDC3 8/20 1.00
CDK1 P06493 8/20 1.00
MAP4K5 Q9Y4K4 8/20 1.00
SRPK1 Q96SB4 8/20 1.00
CSNK1G2 P78368 8/20 1.00
HIPK4 Q8NE63 8/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4721372 0.94 PLK4 (0.89) PLK4MAP4K4MARK3AXLMAP4K2
SCHEMBL4761640 0.89 PLK4 (0.81) PLK4MAP4K4MARK3AXLMAP4K2
SCHEMBL5472353 0.89 KDR (1.00) PLK4MAP4K4MARK3AXLMAP4K2
SCHEMBL5474622 0.89 PLK4 (0.80) PLK4MAP4K4MARK3AXLMAP4K2
SCHEMBL4721617 0.88 PLK4 (0.79) PLK4MAP4K4MARK3AXLMAP4K2
SCHEMBL4721626 0.88 STK3 (0.78) PLK4MAP4K4MARK3AXLMAP4K2
SCHEMBL4720555 0.88 PLK4 (0.89) PLK4MAP4K4MARK3AXLMAP4K2
SCHEMBL4719761 0.88 PLK4 (1.00) PLK4MAP4K4MARK3AXLMAP4K2
SCHEMBL5474949 0.88 MAP4K4 (0.78) PLK4MAP4K4MARK3AXLMAP4K2
SCHEMBL4722423 0.88 PLK4 (1.00) PLK4MAP4K4MARK3AXLMAP4K2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070135387-A1 Inhibitors of protein kinases ABBOTT LABORATORIES 2007-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135387-A1 Inhibitors of protein kinases MAP3K20, PACSIN2, MAP4K2 PLK4 230/4885MAP4K4 31/4885MARK3 402/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.